Some features of a novel Sr-90-Y-90 generator which employs supported liqui
d membrane (SLM) to separate carrier-free Y-90 from Sr-90 present in the hi
gh level waste of the spent fuel of reactor are described. After ascertaini
ng the purity of Y-90 particularly with respect to Sr-90 breakthrough, its
complexation was studied with a few oxo/aza donor Ligands, such as DTPA, ED
TMP, DOTA, TETA and a cyclic phosphonate, CTMP. These studies were primaril
y carried out to adjudge the quality of the Y-90 obtained from a novel Sr-9
0-Y-90 generator and ascertain its usability for labelling biomolecules suc
h as antibodies and peptides. The DOTA complexes are most stable at 37 degr
eesC in human serum; they appear to be ideal bifunctional chelating agent f
or use in radioimmunotherapy with Y-90.